Dr. Octavio Miguel Miguel Rivero-Lezcano majored in Veterinary Medicine, and finished his Ph.D. in 1991. In the past, he has worked in bacterial pathogens (Aeromonas hydrophila), human cancer (non-receptor tyrosine kinases), and pathogenic protozoa (Leishmania spp.). He is currently interested in the immunological response to mycobacterial infections. He has worked mainly with Mycobacterium tuberculosis, but in the last few years, he has been involved with nontuberculous mycobacteria, which are becoming clinically very important, mainly in mycobacteriosis, bronchiectasis, and cystic fibrosis. He tries to improve current in vitro infection models with primary cells originating from blood, such as monocytes and neutrophils.
Dr. Octavio Miguel Miguel Rivero-Lezcano majored in Veterinary Medicine, and finished his Ph.D. in 1991. In the past, he has worked in bacterial pathogens (Aeromonas hydrophila), human cancer (non-receptor tyrosine kinases), and pathogenic protozoa (Leishmania spp.). He is currently interested in the immunological response to mycobacterial infections. He has worked mainly with Mycobacterium tuberculosis, but in the last few years, he has been involved with nontuberculous mycobacteria, which are becoming clinically very important, mainly in mycobacteriosis, bronchiectasis, and cystic fibrosis. He tries to improve current in vitro infection models with primary cells originating from blood, such as monocytes and neutrophils.